Genetic Technologies Ltd (ASX: GTG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Genetic Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $5.67 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 145.42 million
Earnings per share -0.008
Dividend per share N/A
Year To Date Return N/A
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Genetic Technologies Ltd (ASX: GTG)
    Latest News

    a woman
    ⏸️ Investing

    Market wipeout: Stocks crushed in $24 billion rush for the exits

    S&P/ASX 200 sinks 1.3%, but these stocks fared much worse

    Read more »

    a woman
    ⏸️ Investing

    4 stocks soaring on the ASX today

    S&P/ASX 200 closes flat, but these four skyrocketed

    Read more »

    a woman
    ⏸️ Investing

    Genetic Technologies Limited soars 30%: Here's why

    Highly speculative Genetic Technologies Limited (ASX:GTG) could be one to watch

    Read more »

    GTG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Genetic Technologies Ltd

    Genetic Technologies Ltd. is a molecular diagnostics company, which engages in the provision of molecular risk assessment tests for cancer. It operates through EasyDNA and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The GeneType/Corporate segment includes tha GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Campbell Douglas Welch Non-Executive Director Mar 2026
    --
    Mr Michael Malcolm Walker Executive ChairmanManaging Director May 2025
    Mr Walker brings over 20 years of leadership and compliance experience across industries, with a focus on regulatory licensing and financial services. He is the Founder and Investment Manager of Walker Capital, a boutique wealth management firm in discretionary managed portfolios and a Fixed Income Fund. Michael is also the Director and CEO of Ellerfield Financial Planning. In addition, Michael serves as one of the Responsible Managers of Walker Capital Private Wealth Pty Ltd, which operates under an Australian Financial Services Licence (AFSL).
    Mr Jeffrey Michael Le Compte Non-Executive Director Mar 2026
    --
    Ms Priyamvada Sanjay Rasal (Pia) Company Secretary May 2025
    -
    Mr Simon Morriss Chief Executive Officer Feb 2021
    -
    Carl Stubbings Chief Commercial Officer
    -
    Simon Morriss Chief Executive Officer
    -
    Kevin Camilleri Chief Executive Officer EasyDNA
    -
    Kathryn Andrews Chief Financial Officer
    -
    Priyamvada Sanjay Rasal (Pia) Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 103,434,943 71.13%
    Mr Warwick Wright 2,440,000 1.68%
    MJGD Nominees Pty Ltd 2,008,494 1.38%
    Doma 193 Pty Ltd <Doma 193 A/C> 1,445,514 0.99%
    Rip Opportunities Pty Ltd <Pir Super Fund A/C> 1,250,000 0.86%
    Irwin Biotech Nominees Pty Ltd <Bioa A/C> 758,494 0.52%
    Mr Lei Da Tao 685,000 0.47%
    Irwin Biotech Nominees P/L <Bioa A/C> 679,209 0.47%
    Miss Susan Spiteri 557,724 0.38%
    AP 300 Pty Ltd <AP Invest A/C> 480,400 0.33%
    Monument Hill Pty Ltd 420,001 0.29%
    Mrs Helen Kamer and Mr Benjamin Kamer <Kamer Super Fund A/C> 400,000 0.28%
    Ms Carol Yan Lu 400,000 0.28%
    Alwoonee Pty Ltd <The O'Connor Super A/C> 388,959 0.27%
    Mr Wenbo Liu 377,358 0.26%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 354,066 0.24%
    Mr John Christopolous <Chrisand Family A/C> 348,000 0.22%
    Aquasafe Investments Pty Ltd <White Superfund A/C> 306,081 0.21%
    Mr Kar Leong Chong 300,000 0.21%
    Mr Md Touhidur Rahman 300,000 0.21%
    Whalecorp Pty Ltd <Whalecorp Pty Ltd S/F A/C> 300,000 0.21%

    Profile

    since

    Note